Effectiveness of intervention led by a community pharmacist for improving recognition of sleep apnea in primary care - A cohort study

Journal of Sleep Research

Volumn 24, Issue 2, 2015, Pages 167-173

  Perraudin, Clémence ^a   Fleury, Bernard ^b   Pelletier Fleury, Nathalie ^a  

^a EHESS Sciences   (France)

^b ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

Apnea; Pharmacy; Screening

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; EMPLOYMENT STATUS; EPWORTH SLEEPINESS SCALE; FEMALE; FOLLOW UP; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PHARMACIST; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SLEEP DISORDERED BREATHING; SNORING; SOCIAL STATUS; CLINICAL TRIAL; COMPLICATION; DIAGNOSTIC TEST; DISEASE PREDISPOSITION; FRANCE; HEALTH EDUCATION; MANPOWER; MIDDLE AGED; PRIMARY HEALTH CARE; PROBABILITY; PROCEDURES; PROFESSIONAL STANDARD; RISK; SLEEP APNEA, OBSTRUCTIVE; UTILIZATION;

BODY MASS INDEX; COHORT STUDIES; DIAGNOSTIC TESTS, ROUTINE; DISEASE SUSCEPTIBILITY; FEMALE; FRANCE; HEALTH EDUCATION; HUMANS; MALE; MIDDLE AGED; ODDS RATIO; OVERWEIGHT; PHARMACISTS; PRIMARY HEALTH CARE; PROBABILITY; PROFESSIONAL ROLE; SLEEP APNEA, OBSTRUCTIVE; SNORING;

EID: 84923797621     PISSN: 09621105     EISSN: 13652869     Source Type: Journal    
DOI: 10.1111/jsr.12230     Document Type: Article

References (28)

1. Anderson, C. Health promotion in community pharmacy: the UK situation. Patient Educ. Couns., 2000, 39: 285-291.
2. Chapman, J. L., Zechel, A., Carter, Y. H. and Abbott, S. Systematic review of recent innovations in service provision to improve access to primary care. Br. J. Gen. Pract., 2004, 54: 374-381.
3. Deutsch, P. A., Simmons, M. S. and Wallace, J. M. Cost-effectiveness of split-night polysomnography and home studies in the evaluation of obstructive sleep apnoea syndrome. J. Clin. Sleep Med., 2006, 2: 145-153.
4. Dingli, K., Coleman, E. L., Vennelle, M. et al. Evaluation of a portable device for diagnosing the sleep apnoea/hypopnoea syndrome. Eur. Respir. J., 2003, 21: 253-259.
5. Edmunds, J. and Calnan, M. W. The re-professionalization of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and General Practitioners in the United Kingdom. Soc. Sci. Med., 2001, 53: 943-955.
6. Fuhrman, C., Fleury, B., Nguyên, X. L. and Delmas, M.-C. Symptoms of sleep apnoea syndrome: high prevalence and under-diagnosis in the French population. Sleep Med., 2012, 13: 852-858.
7. Fuller, J. M., Wong, K. K., Krass, I., Grunstein, R. and Saini, B. Sleep disorders screening, sleep health awareness, and patient follow-up by community pharmacists in Australia. Patient Educ. Couns., 2011, 83: 325-335.
8. Giles, T. L., Lasserson, T. J., Smith, B. H., White, J., Wright, J. and Cates, C. J. Continuous positive airways pressure for obstructive sleep apnoea in adults. Cochrane Database Syst. Rev., 2006, 3: CD001106.
9. Hersberger, K. E., Renggli, V. P., Nirkko, A. C., Mathis, J., Schwegler, K. and Bloch, K. E. Screening for sleep disorders in community pharmacies - evaluation of a campaign in Switzerland. J. Clin. Pharm. Ther., 2006, 31: 35-41.
10. Hughes, C. M. and McCann, S. Perceived inter-professional barriers between community.pharmacists and general practitioners: a qualitative assessment. Br. J. Gen. Pract., 2003, 53: 600-606.
11. Lindberg, E., Carter, N., Gislason, T. and Janson, C. Role of snoring and daytime sleepiness in occupational accidents. Am. J. Respir. Crit. Care Med., 2001, 164: 2031-2035.
12. Manolakis, P. G. and Skelton, J. B. Pharmacists' contributions to primary care in the United States collaborating to address unmet patient care needs: the emerging role for pharmacists to address the shortage of primary care providers. Am. J. Pharm. Educ., 2010, 74: S7.
13. Marin, J. M., Agusti, A., Villar, I. et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA, 2012, 23: 2169-2176.
14. Meslier, N., Vol, S., Balkau, B. et al. Prevalence of symptoms of sleep apnoea syndrome. Study of a French middle-aged population. Rev. Mal. Respir., 2007, 24: 305-313.
15. Mold, J. W., Quattlebaum, C., Schinnerer, E., Boeckman, L., Orr, W. and Hollabaugh, K. Identification by primary care clinicians of patients with obstructive sleep apnoea: a practice-based research network (PBRN) study. J. Am. Board Fam. Med., 2011, 24: 138-145.
16. Noor, Z. M., Smith, A. J., Smith, S. S. and Nissen, L. M. A study protocol: a community pharmacy-based intervention for improving the management of sleep disorders in the community settings. BMC Health Serv. Res., 2014, 14: 74.
17. Perraudin, C., Brion, F., Bourdon, O. and Pelletier-Fleury, N. The future of pharmaceutical care in France: a survey of final-year pharmacy students' opinions. BMC Clin. Pharmacol., 2011, 11: 6.
18. Perraudin, C., Le Vaillant, M. and Pelletier-Fleury, N. Cost-effectiveness of a community pharmacist-led sleep apnoea screening program - a Markov model. PLoS ONE, 2013, 8: e63894.
19. Santschi, V., Chiolero, A., Burnand, B., Colosimo, A. L. and Paradis, G. Impact of pharmacist care in the management of cardiovascular disease risk factors: a systematic review and meta-analysis of randomized trials. Arch. Intern. Med., 2011, 171: 1441-1453.
20. Simpson, S. H., Johnson, J. A., Biggs, C. et al. Practice-based research: lessons from community pharmacist participants. Pharmacotherapy, 2001, 21: 731-739.
21. Smith, R., Ronald, J., Delaive, K., Walld, R., Manfreda, J. and Kryger, M. H. What are obstructive sleep apnoea patients being treated for prior to this diagnosis? Chest, 2002, 121: 164-172.
22. Sturgess, I. K., McElnay, J. C., Hughes, C. M. and Crealey, G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm. World Sci., 2003, 25: 218-226.
23. Tran, A., Fuller, J. M., Wong, K. K., Krass, I., Grunstein, R. and Saini, B. The development of a sleep disorder screening program in Australian community pharmacies. Pharm. World Sci., 2009, 31: 473-480.
24. Tregear, S., Reston, J., Schoelles, K. and Phillips, B. Continuous positive airway pressure reduces risk of motor vehicle crash among drivers with obstructive sleep apnoea: systematic review and meta-analysis. Sleep, 2010, 33: 1373-1380.
25. Von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C. and Vandenbroucke, J. P. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLOS Med, 2007, 16: e296.
26. World Health Organization (WHO). The Role of the Pharmacist in the Health Care System. Preparing the Future Pharmacist: Curricular Development. WHO, Vancouver, Canada, 1997.
27. Young, T., Peppard, P. E. and Gottlieb, D. J. Epidemiology of obstructive sleep apnoea: a population health perspective. Am. J. Respir. Crit. Care Med., 2002, 165: 1217-1239.
28. Yuksel, N., Majumdar, S. R., Biggs, C. and Tsuyuki, R. T. Community pharmacist-initiated screening program for osteoporosis: randomized controlled trial. Osteoporosis Int., 2010, 21: 391-398.